HomeLab TestsThyroglobulin
Back to Lab Tests
Thyroglobulin
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Lab Tests

Thyroglobulin

The thyroglobulin test is primarily used as a tumor marker to monitor the effectiveness of thyroid cancer treatment and detect potential recurrence.

What is a thyroglobulin test?

This test measures the amount of thyroglobulin (Tg), a protein produced by the thyroid gland, in your blood. While the thyroid normally releases small amounts of this protein, higher levels can be associated with thyroid conditions. Because cancerous cells in papillary carcinoma and follicular thyroid cancer produce thyroglobulin, it is used as a tumor marker—a substance produced by cancer cells or normal cells in response to cancer.

Other conditions, such as hyperthyroidism, hypothyroidism, and thyroiditis (inflammation), can also affect thyroglobulin levels. Therefore, this test is not used to diagnose cancer.

What is it used for?

The test provides valuable information for patients already diagnosed with thyroid cancer, including:

  • Evaluating treatment success: If treatment successfully removes all thyroid tissue, thyroglobulin levels should be very low or undetectable.
  • Predicting prognosis: It helps predict how cancer may behave over time.
  • Monitoring for recurrence: If thyroglobulin is detected after successful treatment, it may indicate that the cancer has returned.

It may also be used to monitor noncancerous thyroid conditions or inflammation caused by viral infections.

Why do I need a thyroglobulin test?

You may need this test before starting cancer treatment to establish a baseline, four to six weeks after treatment to confirm the removal of thyroid tissue, and regularly thereafter to ensure the cancer has not returned.

What happens during the test?

A health care professional will take a blood sample from a vein in your arm using a small needle. The process takes less than five minutes.

Will I need to do anything to prepare?

No special preparation is usually required, but you should inform your provider about all vitamins and supplements you take, as these can interfere with the test.

What do the results mean?

Interpretation depends on your health history and treatment type. Generally:

  • Very low or no thyroglobulin: May indicate that treatment successfully removed all thyroid tissue.
  • High or increasing levels: May indicate that treatment was not fully successful, the cancer has grown or spread, or the cancer has returned.

Is there anything else I need to know?

It is important to have your tests performed at the same laboratory using the same method to ensure results can be accurately compared over time. Additionally, if you have thyroglobulin antibodies, they can attach to thyroglobulin and cause test results to appear falsely low. Your provider will typically order an antibody test to determine if the thyroglobulin test is a reliable monitoring tool for your specific case.

Frequently Asked Questions

Thyroiditis, which is inflammation of the thyroid gland, can cause stored thyroglobulin to leak into the bloodstream, leading to a temporary spike in levels. This can be triggered by viral infections, radiation therapy, or certain medications like interferon. Additionally, pregnancy can naturally elevate levels. It is crucial to distinguish these transient spikes from true recurrence, which is why clinicians often repeat the test after the inflammation subsides or correlate the results with imaging studies like a neck ultrasound.
The frequency of monitoring depends on your initial risk classification. For low-risk patients, testing is typically performed annually for the first five years and then every one to two years thereafter. For high-risk patients, testing may be required every three to six months for the first few years. Your endocrinologist will establish a specific schedule based on your initial tumor size, stage, and response to radioactive iodine therapy.
stable, low-level detectable thyroglobulin (often less than 2 to 5 ng/mL) after total thyroidectomy may represent microscopic residual thyroid tissue rather than active cancer. If the level remains stable over several months and imaging is negative, it is often considered a benign finding. However, any upward trend, even if small, warrants further investigation with a diagnostic whole-body scan or neck ultrasound to rule out persistent or recurrent disease.
If you have thyroid peroxidase (TPO) antibodies, they can interfere with the laboratory assay, causing the test to report a falsely low or undetectable thyroglobulin level even when cancer is present. To ensure accuracy, your doctor will order a separate test for thyroglobulin antibodies (TgAb). If these antibodies are present, the TgAb level itself becomes the primary marker for monitoring disease recurrence, as it correlates with the amount of residual thyroid tissue.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss